has announced the acquisition of an 85% stake in Arinna Lifesciences Limited for INR 175.92 crores, valuing the target company at INR 200 crores enterprise value. Arinna, a CNS-focused pharmaceutical marketing company based in Ahmedabad, reported turnover of INR 71.50 crores in FY 2024-25. Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.